Vasopressin injection for fibroid uterus safe in pregnancy? Safe Dosage ?
Reading File
Finding Sources
Searching PubMed
vasopressin myomectomy pregnancy fibroid uterus
Searching the Web
vasopressin injection fibroid uterus myomectomy pregnancy safety dosage
Reading File
Reading File
Reading Article
Finding Sources
I now have very strong, direct evidence. The PubMed abstract explicitly states vasopressin is contraindicated in pregnancy. Let me compile the full answer.
Vasopressin Injection for Fibroid Uterus - Safety in Pregnancy
Short Answer: Vasopressin is CONTRAINDICATED in Pregnancy
This is not a "use with caution" situation - a 2022 case report from Baylor College of Medicine explicitly lists it as a tip during laparoscopic myomectomy in pregnancy:
"Other hemostasis agents such as vasopressin are contraindicated in pregnancy" - PMID 35490939, Journal of Minimally Invasive Gynecology, 2022
Why Vasopressin is Used in Non-Pregnant Myomectomy
Dilute vasopressin is injected directly into the fibroid or myometrium during myomectomy to achieve hemostasis via:
- Vasoconstriction of smooth muscle in small arterioles, venules, and capillaries within the myometrium
- Reduction in intraoperative blood loss (Cochrane review showed median decrease of ~299 mL)
- It also reduces fluid intravasation during hysteroscopic procedures
Standard non-pregnant dosage protocols:
- Dilution: 20 units (1 mL) vasopressin in 200 mL of 0.9% saline = 0.1 unit/mL concentration
- Maximum dose: 5 units total (= 50 mL of this diluted solution) per procedure
- Never exceed 5 units in a single injection session
- Repeat dose at 45-60 minutes may be considered if needed
- Always aspirate before injecting to avoid intravascular placement
(Source: King Edward Memorial Hospital Myomectomy Guidelines; Berek & Novak's Gynecology; Schwartz's Principles of Surgery)
Why It Is Contraindicated in Pregnancy
| Risk | Mechanism |
|---|---|
| Uterotonic effect | Vasopressin binds V1 receptors on myometrium - causes uterine contraction, can trigger preterm labor or uterine rupture |
| Uteroplacental vasoconstriction | Constricts spiral arteries and uterine vasculature, directly impairing placental perfusion and causing fetal hypoxia |
| Fetal bradycardia | Reduced uteroplacental flow can lead to fetal distress and bradycardia |
| Uterine rupture | Forceful contraction combined with uterine incision creates rupture risk |
| Cardiovascular maternal risk | Systemic vasopressin causes severe hypertension, bradycardia, cardiovascular collapse if injected intravascularly |
What IS Used Instead During Myomectomy in Pregnancy
When myomectomy is unavoidable during pregnancy (e.g., symptomatic, rapidly growing, or degenerating pedunculated fibroids refractory to conservative management), alternative hemostasis strategies are used:
- Suture ligation of the stalk - preferred for pedunculated fibroids (a suture tied around the base of the stalk before transection)
- Bipolar energy/harmonic scalpel for cauterization of the stalk/vessels
- Tourniquet/occlusion of uterine vessels - temporary mechanical occlusion
- Tranexamic acid - antifibrinolytic agent, used pre/intraoperatively
- Minimizing uterine manipulation to reduce uterine irritability
- Misoprostol/oxytocin - with extreme caution and only post-delivery timing considerations
Clinical Bottom Line
- Vasopressin injection for fibroids = safe and effective ONLY in non-pregnant patients
- In pregnancy = CONTRAINDICATED regardless of trimester
- There is no established safe dose of vasopressin for intramyometrial use during pregnancy
- If myomectomy is required during pregnancy (rare, high-risk decision), mechanical and energy-based hemostasis methods replace vasopressin entirely
- The decision to perform myomectomy during pregnancy itself requires specialist-level evaluation; it is generally avoided unless conservative management fails
Clinical note: If a patient with a fibroid uterus requires surgical intervention during pregnancy, this must be managed by a high-risk obstetrics (Maternal-Fetal Medicine) team at a tertiary center.
This is a shared conversation. Sign in to Orris to start your own chat.